loader
Please Wait
Applying Filters...

Digital Content for TTP399

Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2024/03/04/2839535/0/en/vTv-Therapeutics-Announces-FDA-Submission-for-First-Phase-3-Study-of-Cadisegliatin-in-Patients-with-Type-1-Diabetes.html

GLOBENEWSWIRE
04 Mar 2024